McCarty JM, Bedell L, Mendy J, Coates EE, et al. Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals. Vaccine 2023 Sep 8:S0264-410X(23)01052-6. doi: 10.1016/j.vaccine.2023.
PMID: 37690874